SUMMARY Injection of animals with purified acetylcholine receptor in complete Freund's adjuvant causes development of antibodies which crossreact with receptors in muscle. The crossreacting antibodies impair neuromuscular transmission. Animals with experimental autoimmune myasthenia gravis (EAMG) are excellent models for studying the complex mechanisms by which the autoimmune response to receptor in myasthenia gravis causes muscle weakness. This review first briefly describes the discovery of EAMG. Then, to provide the necessary perspective, receptor structure and function and properties of anti-receptor antibodies are discussed, followed by a brief review of the pathological mechanisms in EAMG.
Introduction
In 1960 John Simpson wrote a paper which argued that myasthenia gravis (MG) was caused by antibodies to acetylcholine receptors (AChR) that impaired neuromuscular transmission by competitively inhibiting AChR.1 In 1968 my graduate adviser, Ed Lennox, gave me a copy to read. My thesis project was to purify AChR. Many years before, David Nachmanson2 had introduced the idea of using fish electric organs as a rich source of AChR, but no suitably specific method had been devised for biochemically labelling AChR or assaying their activity, much less purifying them. We were investigating affinity labelling as an approach to identifying AChR biochemically,3 but with considerably less success than Arthur Karlin was enjoying at that time, 4 and in ignorance of the really critical observation by C Y Lee that 1251 labelled snake venom toxins could specifically label AChR. 5 The use of fish electric organs as a source of AChR and 1251 labelled snake venom toxin to identify AChR would ultimately permit both the purification and characterisation of AChR and the understanding of the pathological mechanisms impairing neuromuscular transmission in MG. But at the time I first read Dr Simpson's article, my interest was in using anti-AChR antibodies from MG patients, if they existed, to identify AChR. In the natural course of things, we ended up much later using labelled AChR to identify antibodies in MG patients.6 7 It had initially been thought that snake toxins bound very specifically, but irreversibly to the acetylcholine binding site of AChR.8 Thus, although they would provide a wonderfully specific method for localising and quantitating AChR, they seemed unusable as affinity adsorbents for purifying AChR. In fact, though toxins bind with high affinity to AChR, they can be competitively eluted.9 Using this observation, Jim Patrick and I purified AChR from the electric organs of Electrophorus electricus by solubilising the membrane proteins in Triton X-100, absorbing AChR In the following sections I will briefly outline the current state of our knowledge about the AChR molecule and its role in EAMG.
The AChR molecule Structure of the AChR molecule has been studied most carefully using AChR purified from marine elasmobranch electric organs. AChR synthesis and destruction has been best studied using chicken and rodent muscle cells in tissue culture. AChR function has been best studied using intact amphibian and mammalian muscle tissue. It seems increasingly reasonable to hope that the structure, metabolism and function of the AChR is sufficiently universal that species specific variations are relatively small, and information from all these sources can be integrated to provide a reasonable view of the AChR molecule.
AChR from the electric organ of the marine elasmobranch Torpedo californica contains four strongly associated subunits in the mole ratio a2fly8. [13] [14] [15] The apparent molecular weights of these acidic glycoproteinsl5 16 27 AChR is present at much lower concentration in muscle than in electric organs, and its structure is corresponding less certain. Until recently, there had been disagreement over the structure even of electric organ AChR. Some reports claimed that it was composed only of a subunits,28 but these erroneous results probably resulted from selective proteolysis of the higher molecular weight subunits. Antigenic determinants corresponding to the four subunits of torpedo AChR are observed in both bovine27 and human23 muscle. a-like subunits can be affinity labelled with an acetylcholine binding site directed reagent using AChR from torpedo, eel, or muscle.27 29 However, in rat muscle,29 but not bovine muscle,27 two sizes of chains were labelled. AChR purified from rat muscle contains subunits similar in molecular weight to /3, -y and 8,21 but these have not yet been tested to determine whether they correspond immunochemically to the subunits of torpedo AChR.
AChR metabolism has been most extensively studied by Fambrough, who has recently reviewed this field.30 31 Muscle cells in culture, like denervated or foetal muscle tissue, rapidly turn over their AChR. AChR at normal, mature synapses are turned over much more slowly, but it is presumed that the same basic mechanisms are involved. The "junctional" AChR present at neuromuscular junctions are suspected to differ from "extrajunctional" AChR of denervated muscle by a structural modification that alters their ligand affinity, isoelectric point,32 and immunochemical properties,27 33 
